These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 34162127)

  • 21. Identification of a PLCE1‑regulated competing endogenous RNA regulatory network for esophageal squamous cell carcinoma.
    Yang Z; Hui Y; Peng H; Zhang H; Li M; Song L; Li F; Cui X
    Oncol Rep; 2021 Mar; 45(3):857-868. PubMed ID: 33650665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.
    Hu JM; Liu K; Liu JH; Jiang XL; Wang XL; Chen YZ; Li SG; Zou H; Pang LJ; Liu CX; Cui XB; Yang L; Zhao J; Shen XH; Jiang JF; Liang WH; Yuan XL; Li F
    Oncotarget; 2017 Mar; 8(13):21526-21538. PubMed ID: 28423526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive Phenotype of Esophagus Tumors Stroma.
    Kovaleva OV; Rashidova MA; Samoilova DV; Podlesnaya PA; Mochalnikova VV; Gratchev A
    Anal Cell Pathol (Amst); 2020; 2020():5424780. PubMed ID: 32884895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
    Li S; Liu Z; Chen Q; Chen Y; Ji S
    Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis.
    Li J; Zeng Z; Jiang X; Zhang N; Gao Y; Luo Y; Sun W; Li S; Ren J; Gong Y; Xie C
    Sci Rep; 2020 Oct; 10(1):18589. PubMed ID: 33122682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma.
    Park S; Joung JG; Min YW; Nam JY; Ryu D; Oh D; Park WY; Lee SH; Choi Y; Ahn JS; Ahn MJ; Park K; Sun JM
    J Immunother Cancer; 2019 May; 7(1):128. PubMed ID: 31097034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis.
    Zhang X; Peng L; Luo Y; Zhang S; Pu Y; Chen Y; Guo W; Yao J; Shao M; Fan W; Cui Q; Xi Y; Sun Y; Niu X; Zhao X; Chen L; Wang Y; Liu Y; Yang X; Wang C; Zhong C; Tan W; Wang J; Wu C; Lin D
    Nat Commun; 2021 Sep; 12(1):5291. PubMed ID: 34489433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Novel Tumor Microenvironment-Related Prognostic Gene AIF1 May Influence Immune Infiltrates and is Correlated with TIGIT in Esophageal Cancer.
    Xu X; Wang D; Li N; Sheng J; Xie M; Zhou Z; Cheng G; Fan Y
    Ann Surg Oncol; 2022 May; 29(5):2930-2940. PubMed ID: 34751872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.
    Wang C; Li Y; Wang L; Han Y; Gao X; Li T; Liu M; Dai L; Du R
    Br J Cancer; 2024 May; 130(11):1770-1782. PubMed ID: 38600327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment.
    Dinh HQ; Pan F; Wang G; Huang QF; Olingy CE; Wu ZY; Wang SH; Xu X; Xu XE; He JZ; Yang Q; Orsulic S; Haro M; Li LY; Huang GW; Breunig JJ; Koeffler HP; Hedrick CC; Xu LY; Lin DC; Li EM
    Nat Commun; 2021 Dec; 12(1):7335. PubMed ID: 34921160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma.
    Yuan X; Li Y; Zhang AZ; Jiang CH; Li FP; Xie YF; Li JF; Liang WH; Zhang HJ; Liu CX; Pang LJ; Shen XH; Li F; Hu JM
    Aging (Albany NY); 2020 Dec; 13(2):2049-2072. PubMed ID: 33323552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
    Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
    Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
    Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
    Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
    Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
    BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
    Jin D; Yuan L; Li F; Wang S; Mao Y
    BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma.
    Ma C; Luo H
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment.
    Wang Z; Chen M; Qiu Y; Yang Y; Huang Y; Li X; Zhang W
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33543230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Prognostic Related Genes of Tumor Microenvironment Derived From Esophageal Cancer Patients.
    Yuan W; Yan J; Liu H; Li L; Wu B; Guo C; Zhang M
    Pathol Oncol Res; 2021; 27():589662. PubMed ID: 34257539
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhancer demethylation-regulated gene score identified molecular subtypes, inspiring immunotherapy or CDK4/6 inhibitor therapy in oesophageal squamous cell carcinoma.
    Gao W; Liu S; Wu Y; Wei W; Yang Q; Li W; Chen H; Luo A; Wang Y; Liu Z
    EBioMedicine; 2024 Jul; 105():105177. PubMed ID: 38924839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.